![]() |
시장보고서
상품코드
1397179
세계의 혈류 측정 기기 시장 : 통찰, 경쟁 구도, 시장 예측(2028년)Blood Flow Measurement Devices - Market Insights, Competitive Landscape and Market Forecast-2028 |
세계의 혈류 측정 기기(Blood Flow Measurement Devices) 시장 규모는 2023년부터 2028년까지의 예측 기간 동안 9.1%의 CAGR로 확대될 것으로 예측됩니다. 혈류 측정 기기 수요는 세계에서 다양한 심혈관 질환, 당뇨병 및 기타 만성 질환의 증례가 증가하고 있다는 배경에 있습니다. 또한 심혈관 수술, 복강경 수술 및 기타 수술 증가, 제품 기술 진보, 노인 인구 증가, 제품 출시 및 승인 증가 등도 2023-2028년의 예측 기간 동안 혈류 측정 기기 시장의 전반적인 성장에 기여합니다.
혈류 측정 기기 시장은 다양한 요인에 의해 제품 수요가 증가하고 있지만, 주요 요인 중 하나는 뇌졸중, 심장마비 등 심장 질환의 유병률이 증가하는 것입니다.
예를 들어 미국 질병예방관리센터(CDC) 2022에 따르면 매년 미국에서는 약 80만 5,000명이 심장 발작을 일으키며, 이 중 60만 5,000명이 처음으로 심장 발작을 경험했으며, 20만 건 가까이 이미 심장 발작을 일어난 사람에게 일어나고 있습니다. 혈류 모니터링 장치는 심장 마비 환자 관리에 중요한 역할을 하며, 의료 서비스 제공업체는 개입의 효능을 평가하고, 치유 과정을 모니터링하며, 치료 전략을 최적화할 수 있습니다. 따라서 혈류 모니터링 장치는 심혈관 치료, 개인화 된 치료 및 심장 발작 위험이있는 개인의 결과 개선에 기여하기 때문에 심혈관 질환의 유병률이 증가함에 따라 수요가 증가함에 따라 예상됩니다.
혈류 측정 기기 시장은 최첨단 혈류 측정 기기에 집중하는 여러 연구 개발의 결과로 확대되고 있습니다. 예를 들어 Sree ChitraTirunal Institute for Medical Sciences and Technology의 연구자 그룹이 고안한 참신하고 합리적인 가격의 혈류계는 인도 정부의 과학 기술부에 의해 다루어졌습니다. 연구자들은 이 손바닥 크기의 장비는 국내 및 국제 기준과 지침을 준수하며 국내 확립된 공급망에서 조달한 부품을 사용하여 제조된다고 주장했습니다. 이 장치는 새로운 자기 방법과 신호 조정 기술을 사용하여 혈류량을 측정합니다. 이러한 요인이 2023-2028년 예측기간 중 혈류 측정 기기 시장의 성장에 기여 할 것으로 예상됩니다.
그러나 장비의 높은 비용, 정확성 및 가짜 결과 우려 등이 혈류 측정 기기 시장 성장을 제한할 수 있습니다.
세계의 혈류 측정 기기(Blood Flow Measurement Devices) 시장에 대해 조사했으며, 시장 개요/제품별·용도별·최종 사용자별·지역별 동향/시장 진출 기업 개요 등을 제공합니다.
Blood Flow Measurement Devices Market By Product (Ultrasound Devices [Ultrasound Doppler And Transit-Time Flow Meters] And Laser Doppler Flow Meter), Application (Invasive And Non-Invasive), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the increasing prevalence of cardiovascular diseases and the rising demand of biodegradable blood flow sensors across the globe.
The global blood flow measurement devices market is estimated to grow at a CAGR of 9.1% during the forecast period from 2023 to 2028. The demand for blood flow measurement devices is being boosted due to the rising cases of various cardiovascular diseases, diabetes, and other chronic diseases across the globe. Further, the increasing number of cardiovascular surgeries, laparoscopic surgery, and other surgeries along with the advancements in product technologies, rising geriatric population base, rising product launches and approvals, among others are also contributing to the overall growth of the blood flow measurement devices market during the forecast period from 2023-2028.
The blood flow measurement devices market is witnessing a growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of cardiac diseases such as stroke, heart attack, and others.
For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, every year, about 805,000 people in the United States have a heart attack, and out of these, 605,000 people suffer from their first heart attack and nearly 200,000 cases happen to people who already had a heart attack. Blood flow monitoring devices play a crucial role in managing heart attack patients, allowing healthcare providers to assess the effectiveness of interventions, monitor healing progress, and optimize treatment strategies. Thus, the demand for blood flow monitoring devices is expected to increase with the increasing prevalence of cardiovascular diseases as they contribute to better cardiovascular care, personalized treatment, and improved outcomes in individuals at risk of heart attacks.
According to the Organization for Economic Co-operation and Development (OECD) 2023, in 2021 the cases of laparoscopic appendectomy in Denmark were 7064 and the cases of laparoscopic cholecystectomy were 7672. Laparoscopic surgeries, often require precise manipulation of tissues and organs, which can potentially impact blood flow in the surgical site. To ensure optimal patient outcomes, surgeons need accurate real-time information on blood flow during these procedures, ultimately increasing the demand for blood flow measurement devices, and thereby propelling the overall market of blood flow measurement devices in the market.
The market for blood flow device measurement is expanding as a result of several research and development studies that concentrate on cutting-edge blood flow measurement devices. For instance, a novel, reasonably priced blood flow meter devised by a group of researchers at the Sree ChitraTirunal Institute for Medical Sciences and Technology was addressed by the Government of India's Ministry of Science & Technology. The researchers claimed that the palm-sized device complies with national and international standards and guidelines and is manufactured using components sourced from well-established supply chains domestically. It measures blood flow rate using a novel magnetic method and a signal conditioning technique.
Therefore, the above-mentioned factors are contributing to the growth of the blood flow measurement devices market during the forecast period from 2023-2028.
However, the high cost of the device, accuracy or false result concerns, and others may restrict the blood flow measurement device's market growth.
Blood flow measurement devices market by Product (Ultrasound Devices [Ultrasound Doppler and Transit-Time Flow Meters] and Laser Doppler Flow Meter), Application (Invasive and Non-Invasive), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the application segment of the blood flow measurement device non-invasive blood flow category is expected to amass significant revenue share in the year 2023. This can be due to the significant advantages of non-invasive techniques.
These devices provide a non-invasive method of measuring blood flow, eliminating the need for invasive procedures and reducing patient discomfort and potential complications. The convenience and ease of use associated with non-invasive blood flow meters make them suitable for a wide range of healthcare professionals and medical disciplines.
Additionally, because they offer a patient-centric approach to healthcare, their capacity to increase patient comfort and happiness contributes to their expanding demand. Thus, increased demand for non-invasive blood flow meters is being driven positively by the benefits of convenience, patient comfort, adaptability, and alignment with preventative healthcare across a range of medical specializations and healthcare settings.
Furthermore, coupled with the factors mentioned above, strategic activities such as product launches and approvals will also increase the demand for non-invasive blood flow meters. For instance, in March 2020, the FDA approved a flow patch, a non-invasive cardiovascular blood flowmeter, by Flosonics Medical. FloPatch is the world's first wireless, wearable Doppler ultra-sound system that helps clinicians better manage intravenous (IV) fluid therapy earlier in the sepsis care pathway. Thus, such strategic steps help to increase the demand for non-invasive blood flow meter devices.
Therefore, the advantages offered by non-invasive blood flow measurement devices, increasing product launches and approvals, and others are predicted to contribute to the increasing demand for this category, thereby driving the growth of the overall blood flow measurement devices market during the forecast period.
Among all the regions, North America is estimated to account for the largest share in the blood flow measurement devices market in the year 2022 owing to key growth factors such as the rising prevalence of coronary heart diseases, increasing number of surgeries, and others. Additionally, the rise in the adoption of highly advanced techniques and systems in the manufacturing of blood flow measurement devices, the increasing product launches, surging technological advancements, and others are driving the North American blood flow measurement devices market. Furthermore, sophisticated healthcare infrastructure, regulatory approval for new products, and others also helped the market growth in this region.
As per the Department of Health New York State (2020), coronary heart disease (CHD) is the most common type of heart disease, killing approximately 382,820 people annually, in the US. Also, every year about 805,000 Americans have a heart attack. The source also stated that an estimated 18.9% of New Yorkers aged 65 and older reported having some type of Cardiovascular Disease (CVD) in 2020. Blood flow monitoring devices provide valuable information about the rate, velocity, and quality of blood flow, allowing healthcare professionals to evaluate the severity of arterial blockages, monitor the effectiveness of interventions, and guide treatment decisions that can manage life-threatening conditions in cardiovascular illness. Thus, the demand for blood flow monitoring devices is increasing as a result of the rising frequency of cardiovascular illnesses.
Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in June 2023, US-based digital health company STAT Health introduced a 24/7 in-ear wearable general wellness product that measures blood flow to the head to allow a better understanding of conditions in the body that occur upon standing. Therefore, such strategic steps help to increase the demand for blood flow monitoring devices in the North America region.
Therefore, the factors mentioned above help in boosting regional product demand. Thereby, driving the North American blood flow measurement devices market forward during the forecast period.
Some of the key market players operating in the blood flow measurement devices market include: Cook, Medistim, Compumedics Limited, Permed AB, Deltex Medical Limited, Koninklijke Philips N.V., Getinge, Arjo, ATYS Medical, Moor Instruments Limited, Medtronic, AKW Medical, Inc., D. E. Hokanson, Inc., ELCAT GmbH, Oxford Optronix, QT Medical Inc. Transonic, Carolina Medical Electronics, ADINSTRUMENTS, STAT Health Informatics, Inc., and others.